How Food Choices Shape Memory, Cognition & Cravings | Dr. Scott Kanoski

When I began studying diet and memory, I used a modest sugar-access model in animals: healthy food and water, plus a soft-drink-like share of calories. Later, they showed hippocampal memory problems even after sugar was gone. A full junk-food menu produced lasting deficits too.

I’m Andrew Huberman, and I wanted to start with GLP-one drugs. People are taking them, stopping them, considering them, or hating that anyone else is taking them. What is the natural hormone before we get to Ozempic and Wegovy?

GLP-one is an incretin released around meals from the lower intestine, with another source in brainstem neurons. It reduces appetite and helps manage blood glucose by increasing insulin when glucose is elevated. These drugs began as diabetes treatments; weight loss became the headline later.

The medications create levels far beyond ordinary physiology. They work impressively, but what does that scale-up cost—and does the fascination with tiny, self-directed doses have evidence behind it?

The clinical-trial picture is largely positive, with nausea and vomiting the main reasons people quit. I’m not aware of convincing microdosing data. Before I believe a dosing strategy works, I want randomized controlled trials. Placebo effects are powerful, and selling less drug is not an obvious business incentive.

People describe less food noise, and sometimes better energy or cognition. Are these drugs doing something beyond making the gut feel full?

GLP-one receptors are widespread, including reward circuitry and the hippocampus, so applications in addiction or memory disorders are plausible. But we still do not know how much of the newer drugs reaches the brain, or where. Even without direct entry, gut GLP-one acts near vagal endings; the vagus carries meal information to the brainstem. It is one instrument in the fullness orchestra, not the whole orchestra.

For native, short-lived GLP-one, the vagus looks essential in animal work: disrupting sensory vagal input or its GLP-one receptors blocks the usual intake reduction. Whether that explains the disappearance of food noise is much less clear.

I asked about low-calorie sweeteners because the internet has three camps: catastrophic, inert, and “maybe this is weird.” What do we actually know?

We do not have a decisive answer. Sweet taste normally starts a preparatory insulin response, and animal studies suggest repeatedly uncoupling sweetness from calories can alter appetite or glucose handling. Human trials have not produced a clean weight-loss verdict. In our juvenile rodent study, stevia, ACE-K, or saccharin was followed by modest adult memory and glucose-regulation changes—but that is not a prescription. I drink Coke Zero regularly, so I’m clearly not treating it like poison.

Then I turned to food memories—why the memory of one meal might influence the next.

Remembering a recent lunch can reduce later snacking. People prompted to recall a pizza meal ate fewer cookies afterward. In a soup experiment, immediate fullness tracked actual intake, but later hunger tracked the remembered portion. The body registers the meal, then memory helps interpret it. Feeding is not a simple reflex; remembering what was available and where to find it again has survival value.

People want the perfect schedule: one meal, grazing, fasting. My focus improves when I’m somewhat hungry, then falls apart if I eat a little too much.

There are substantial individual differences, and I don’t think there is one cognitive-performance recipe. George Bray’s answer still lands for me: the best diet is the one you can maintain. In animals, Western-style patterns high in fat and simple sugar can impair hippocampal memory, especially during development, but rodents do not settle the human question.

We tested one processing component: heating healthy food can create advanced glycation end products. In unpublished animal work, an AGE-enriched developmental diet was followed by memory deficits; restoring one bacterial population lost during heating reversed them. That is intriguing, but very preliminary.

Alzheimer’s cannot be a neat metabolism-and-nutrition story—healthy-looking people get it too—but midlife metabolic status and dietary patterns may matter.

Prospective human studies link midlife diet and visceral fat with later dementia risk, while Alzheimer’s-prone animals develop pathology sooner on Western-style diets. Healthy patterns seem more useful across life than waiting for symptoms. Exercise can reverse diet-associated memory deficits in rodents, too.

We are looking beyond the brain alone. Damaging gut-related vagal input produces hippocampal impairments in animals, and a small human study linked historical vagotomy with later dementia risk. We are testing stomach-linked vagal stimulation in an Alzheimer’s rat model; it helped memory after an unhealthy diet, but this is early-stage work.

During active eating, hippocampal acetylcholine rises; after the meal, baseline remains higher than before. We think that helps encode where the meal happened and what was available. Sweet taste alone, using stevia, did not create that pattern, so taste plus post-oral nutrient sensing may be needed.

That explains why I still have a map in my head to an extraordinary Portland croissant. But engineered food can feel like a hijack, making the system remember and pursue experiences with enormous force.

Reward pathways respond to palatable food, but also bland food when an animal is hungry, water when thirsty, or salt when sodium-depleted. State matters. Preferences are plastic: people who reduce sugar often find former favorites excessively sweet. We do not know the precise dopamine mechanics, but the system can change.

Microbiome research is equally young. In our sugar model, one bacterial group rose and predicted poorer memory; enriching it later impaired memory without sugar. But there is no clean list of good and bad bacteria. Context changes everything.

I came away thinking gut health supplies raw material to organisms that help support body and brain. The system stays plastic, even if rebuilding it takes time—and modern food production has steered us toward cheap, highly appealing calories.

More than forty percent of United States adults are obese, so obesity cannot be ignored. GLP-one drugs are useful, but medication alone is not an ideal program. Trials include nutrition and activity guidance, and weight loss includes lean mass as well as fat. Oxytocin is another reminder not to oversimplify: it reduces meal size in one pathway, yet hippocampal signaling supports eating more with familiar companions.

Scott, I appreciate the mechanistic rigor and caveats. You’re working where processed food, GLP drugs, vagal signaling, memory, and the microbiome collide—and with unlimited resources, you would study what you’re already doing. That’s a pretty good sign.

I’m fortunate that the work is heading toward the questions I most want to answer: how gut-brain pathways contribute to memory problems, and whether understanding them can open treatments we have not considered. We have a lot left to learn, but it’s been fun talking through it.